Skip to main content

BMJ Journals

  • Log In More
    Log in via Institution
    Log in via OpenAthens

    Log in using your username and password

    For personal accounts OR managers of institutional accounts
    Forgot your log in details?Register a new account?
    Forgot your user name or password?
  • Basket
  • Search More
    Advanced search
Journal for ImmunoTherapy of Cancer
  • Latest content
  • Browse by collection
  • Archive
  • Authors
  • About

Advanced search

  • Close More

    Main menu

    • Latest content
    • Browse by collection
    • Archive
    • Authors
    • About
  • Log in More
    Log in via Institution
    Log in via OpenAthens

    Log in using your username and password

    For personal accounts OR managers of institutional accounts
    Forgot your log in details?Register a new account?
    Forgot your user name or password?
  • BMJ Journals

You are here

  • Home
  • TGF-β
Email alerts

TGF-β

  • Dual targeting of TGF-β and PD-L1 via a bifunctional anti-PD-L1/TGF-βRII agent: status of preclinical and clinical advances
    Hanne Lind, Sofia R Gameiro, Caroline Jochems, Renee N. Donahue, Julius Strauss, James L Gulley, Claudia Palena, Jeffrey Schlom
    Journal for ImmunoTherapy of Cancer Feb 2020, 8 (1) e000433; DOI: 10.1136/jitc-2019-000433
  • Quick efficacy seeking trial (QuEST1): a novel combination immunotherapy study designed for rapid clinical signal assessment metastatic castration-resistant prostate cancer
    Jason M. Redman, Seth M. Steinberg, James L. Gulley
    Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 91; DOI: 10.1186/s40425-018-0409-8
  • Special collections
    • COVID-19 (37)
    • Editor's choice
    • JITC
      • Basic Tumor Immunology (382)
      • Case Reports (178)
      • Clinical Trials Monitor (16)
      • Clinical/Translational Cancer Immunotherapy (697)
      • Commentary/Editorials (114)
      • COVID-19 and Cancer Immunotherapy (10)
      • Emerging Immunotherapeutic Agents (5)
      • Guidelines and Consensus Statements (36)
      • Guidelines and Consensus Statements (24)
      • Imaging and Immunotherapy
      • Immune Cell Therapies and Immune Cell Engineering (113)
      • Immune Checkpoints - Beyond PD-1 (8)
      • Immune Checkpoints Beyond PD-1 Series (8)
      • Immune Monitoring Technology Primers (12)
      • Immunotherapy Biomarkers (281)
      • Microbial-Based Cancer Immunotherapy (4)
      • Oncolytic and Local Immunotherapy (90)
      • Reviews (189)
    • Open access (2327)
    • Press releases
  • Society for Immunotherapy of Cancer
  • Content
    • Latest content
    • Browse by collection
    • Archive
  • Journal
    • About
    • Editorial board
    • Thank you to our reviewers
    • Sign up for email alerts
  • Authors
    • Instructions for authors
    • Submit an article
    • Open Access at BMJ
  • Help
    • Contact us
    • Reprints
    • Permissions
    • Advertising
    • Feedback form
  • RSS
  • Twitter
  • Website Terms & Conditions
  • Privacy & Cookies
  • Contact BMJ

Online: ISSN 2051-1426
Copyright © 2022 BMJ Publishing Group Ltd & Society for Immunotherapy of Cancer. All rights reserved.